Sherbrooke Park Advisers’s Johnson & Johnson JNJ Stock Holding History

Sherbrooke Park Advisers’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,052	Closed	-$1.23M	–	626
2025 Q2	$1.23M	Buy	+8,052	New	+$1.24M	0.53%	22
2025 Q1	–	Sell	-10,597	Closed	-$1.53M	–	769
2024 Q4	$1.53M	Buy	+10,597	New	+$1.64M	0.49%	8
2024 Q3	–	Sell	-12,219	Closed	-$1.79M	–	1080
2024 Q2	$1.79M	Sell	12,219 -9,949	-45%	-$1.48M	0.31%	48
2024 Q1	$3.51M	Buy	22,168 +11,212	+102%	+$1.78M	0.68%	1
2023 Q4	$1.72M	Buy	+10,956	New	+$1.68M	0.81%	9
2023 Q1	–	Sell	-2,700	Closed	-$477K	–	252
2022 Q4	$477K	Buy	+2,700	New	+$466K	0.35%	129

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sherbrooke Park Advisers's JNJ Position: Q3 2025 in Review

Sherbrooke Park Advisers sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 8,052 shares — an estimated $1.23M sold.

Sherbrooke Park Advisers first reported a position in JNJ in Q4 2022 and held it in 6 quarters. The position peaked at $3.51M in Q1 2024. 4,188 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

Sherbrooke Park Advisers reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
Sherbrooke Park Advisers sold 8,052 Johnson & Johnson shares in Q3 2025, an estimated $1.23M.
Sherbrooke Park Advisers first reported a position in Johnson & Johnson in Q4 2022 and held it in 6 quarters.
Sherbrooke Park Advisers's Johnson & Johnson position peaked at $3.51M in Q1 2024.
4,188 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.